Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -40.65% is 40% below its 5-year average of -29.09%, near the low end of its 5-year range (-47.09%–-16.89%).
As of the fiscal period ended Tuesday, June 30, 2026. 28.76% below its 12-month average of -31.57%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -40.65%.
RETURN ON INVESTED CAPITAL (ROIC)
-40.65%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-31.57%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-26.88%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-29.09%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-28.76%
CURRENT VS 3Y AVG
-51.22%
CURRENT VS 5Y AVG
-39.70%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.66%
median of 825 covered companies
CURRENT VS SECTOR MEDIAN
-13.98%
vs the sector median at left
Vaxcyte, Inc.
Market Cap
$9.34B
Return on Invested Capital (ROIC)
-40.65%
TTM Avg
-31.57%
3Y Avg
-26.88%
5Y Avg
-29.09%
Market Cap
$9.38B
Return on Invested Capital (ROIC)
16.04%
TTM Avg
12.65%
3Y Avg
9.01%
5Y Avg
7.29%
Market Cap
$9.29B
Return on Invested Capital (ROIC)
2.56%
TTM Avg
2.83%
3Y Avg
6.99%
5Y Avg
7.71%
Market Cap
$9.61B
Return on Invested Capital (ROIC)
14.41%
TTM Avg
9.77%
3Y Avg
-4.93%
5Y Avg
-7.04%
Market Cap
$9.65B
Return on Invested Capital (ROIC)
6.53%
TTM Avg
6.69%
3Y Avg
7.80%
5Y Avg
8.31%
Market Cap
$9.00B
Return on Invested Capital (ROIC)
-50.82%
TTM Avg
-63.49%
3Y Avg
-63.78%
5Y Avg
-84.79%
Market Cap
$8.98B
Return on Invested Capital (ROIC)
2.56%
TTM Avg
2.83%
3Y Avg
6.99%
5Y Avg
7.71%
Market Cap
$8.79B
Return on Invested Capital (ROIC)
6.74%
TTM Avg
5.23%
3Y Avg
-19.49%
5Y Avg
-23.68%
Market Cap
$8.73B
Return on Invested Capital (ROIC)
-12.12%
TTM Avg
-26.48%
3Y Avg
-28.91%
5Y Avg
-26.88%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Vaxcyte, Inc. (PCVX) | $9.34B | -40.65% | -31.57% | -26.88% | -29.09% |
| Insulet Corp. (PODD)vs › | $9.38B | 16.04% | 12.65% | 9.01% | 7.29% |
| Bruker Corporation (BRKR)vs › | $9.29B | 2.56% | 2.83% | 6.99% | 7.71% |
| Krystal Biotech, Inc. (KRYS)vs › | $9.61B | 14.41% | 9.77% | -4.93% | -7.04% |
| Henry Schein, Inc. (HSIC)vs › | $9.65B | 6.53% | 6.69% | 7.80% | 8.31% |
| Axsome Therapeutics, Inc. (AXSM)vs › | $9.00B | -50.82% | -63.49% | -63.78% | -84.79% |
| Bruker Corporation (BRKRP)vs › | $8.98B | 2.56% | 2.83% | 6.99% | 7.71% |
| Protagonist Therapeutics, Inc. (PTGX)vs › | $8.79B | 6.74% | 5.23% | -19.49% | -23.68% |
| Arrowhead Pharmaceuticals, Inc. (ARWR)vs › | $8.73B | -12.12% | -26.48% | -28.91% | -26.88% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $10.01B | 1.54% | 2.53% | 2.92% | 2.77% |
ROIC
-40.6%
ROE
-38.6%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -40.65% |
| 2026-03-31 | -34.98% |
| 2025-12-31 | -32.45% |
| 2025-09-30 | -27.26% |
| 2025-06-30 | -22.51% |
| 2025-03-31 | -19.38% |
| 2024-12-31 | -16.89% |
| 2024-09-30 | -17.53% |
| 2024-06-30 | -28.79% |
| 2024-03-31 | -25.51% |
| 2023-12-31 | -37.07% |
| 2023-09-30 | -25.38% |
| 2023-06-30 | -21.04% |
| 2023-03-31 | -27.66% |
| 2022-12-31 | -24.05% |
| 2022-09-30 | -47.09% |
| 2022-06-30 | -37.76% |
| 2022-03-31 | -31.89% |
| 2021-12-31 | -35.07% |
| 2021-09-30 | -30.42% |
| 2021-06-30 | -27.61% |
| 2021-03-31 | -26.01% |
| 2020-12-31 | -25.89% |
| 2020-09-30 | -23.60% |
| 2020-06-30 | -20.03% |
| 2020-03-31 | -49.13% |
| 2019-12-31 | -99.10% |
